Sonic Healthcare Limited
SHL
Rang in aandelen
#2845
Sonic Healthcare Limited delivers medical diagnostic services to a diverse... Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
Aandeelprijs
$13.26
Marktkapitalisatie
$6.55B
Verandering (1 dag)
-0.21%
Verandering (1 jaar)
-4.48%
Land
AU
Handel Sonic Healthcare Limited (SHL)
Categorie
Healthcare
P/B-ratio voor Sonic Healthcare Limited (SHL)
P/B-ratio op October 2026 TTM: 1.10
Volgens de meest recente financiële rapporten en aandelenkoers van Sonic Healthcare Limited is de huidige P/B-ratio (TTM) 1.10. Eind 2024 had het bedrijf een P/B-ratio van 1.54.
P/B-ratiohistoriek voor Sonic Healthcare Limited van 2000 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 1.10 | -29.31% |
| 2025 | 1.55 | 0.41% |
| 2024 | 1.54 | -28.56% |
| 2023 | 2.16 | -0.47% |
| 2022 | 2.17 | -24.41% |
| 2021 | 2.87 | 10.75% |
| 2020 | 2.59 | 15.19% |
| 2019 | 2.25 | -9.23% |
| 2018 | 2.48 | -5.93% |
| 2017 | 2.64 | 9.16% |
| 2016 | 2.41 | -7.84% |
| 2015 | 2.62 | 16.48% |
| 2014 | 2.25 | 13.87% |
| 2013 | 1.98 | 3.32% |
| 2012 | 1.91 | -3.84% |
| 2011 | 1.99 | 25.54% |
| 2010 | 1.58 | -10.98% |
| 2009 | 1.78 | -27.05% |
| 2008 | 2.44 | -22.67% |
| 2007 | 3.15 | -0.90% |
| 2006 | 3.18 | -17.65% |
| 2005 | 3.86 | 37.00% |
| 2004 | 2.82 | 39.04% |
| 2003 | 2.03 | 42.72% |
| 2002 | 1.42 | -45.74% |
| 2001 | 2.62 | -29.29% |
| 2000 | 3.71 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| 4.7411 | 332.70% |
US
|
|
| 3.0143 | 175.10% |
US
|
|
| 31.051 | 2,733.90% |
US
|
|
| - | - |
CN
|
|
| 6.6641 | 508.20% |
US
|
